Antiproliferative action of melatonin on human prostate cancer LNCaP cells

scientific article published on 01 March 2000

Antiproliferative action of melatonin on human prostate cancer LNCaP cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID10671684

P2093author name stringMotta M
Limonta P
Moretti RM
Dondi D
Marelli MM
Maggi R
P433issue2
P921main subjectprostate cancerQ181257
P304page(s)347-351
P577publication date2000-03-01
P1433published inOncology ReportsQ7092098
P1476titleAntiproliferative action of melatonin on human prostate cancer LNCaP cells
P478volume7

Reverse relations

cites work (P2860)
Q36083886Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies
Q36142304Does night-shift work increase the risk of prostate cancer? a systematic review and meta-analysis
Q35947279Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions.
Q34554008Melatonin Induces Apoptotic Cell Death via p53 in LNCaP Cells
Q99565353Melatonin and urological cancers: a new therapeutic approach
Q33624824Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis
Q58587207Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers
Q28388457Night shift work and levels of 6-sulfatoxymelatonin and cortisol in men
Q35754518Residential Exposure to Road and Railway Noise and Risk of Prostate Cancer: A Prospective Cohort Study
Q36839618Sleep disruption among older men and risk of prostate cancer
Q35054661Urinary melatonin levels, sleep disruption, and risk of prostate cancer in elderly men
Q28077467WOMEN IN CANCER THEMATIC REVIEW: Circadian rhythmicity and the influence of 'clock' genes on prostate cancer